{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:26:19Z","timestamp":1791296779590,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T00:00:00Z","timestamp":1461801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["222895"],"award-info":[{"award-number":["222895"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["222895"],"award-info":[{"award-number":["222895"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["121474"],"award-info":[{"award-number":["121474"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["G051812N"],"award-info":[{"award-number":["G051812N"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["G058916N"],"award-info":[{"award-number":["G058916N"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11V4215N"],"award-info":[{"award-number":["11V4215N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Grants","award":["SAF2011-28102"],"award-info":[{"award-number":["SAF2011-28102"]}]},{"name":"Spanish Grants","award":["SAF2012-34267"],"award-info":[{"award-number":["SAF2012-34267"]}]},{"DOI":"10.13039\/501100006461","name":"Agencia de Innovaci\u00f3n y Desarrollo de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CTS-7282"],"award-info":[{"award-number":["CTS-7282"]}],"id":[{"id":"10.13039\/501100006461","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Trust Sanger","award":["098051"],"award-info":[{"award-number":["098051"]}]},{"name":"Wellcome Trust Sanger","award":["098051"],"award-info":[{"award-number":["098051"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154101","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T14:54:20Z","timestamp":1461855260000},"page":"e0154101","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":93,"title":["Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes"],"prefix":"10.1371","volume":"11","author":[{"given":"Annelies","family":"Mondelaers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Sanchez-Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hendrickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Eberhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Garcia-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lachaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Cuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Delputte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gamarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Castanys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-9509","authenticated-orcid":true,"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,28]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1473-3099(10)70320-0","article-title":"Visceral leishmaniasis: elimination with existing interventions","volume":"11","author":"G Matlashewski","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"S Sundar","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"ref3","first-page":"666","article-title":"Kala-azar elimination programme in India","volume":"106","author":"GP Dhillon","year":"2008","journal-title":"J Indian Med Assoc"},{"issue":"22","key":"ref4","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"S Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"S Sundar","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"S Rijal","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jprot.2014.05.010","article-title":"Proteomic analysis of the soluble proteomes of miltefosine-sensitive and -resistant <italic>Leishmania infantum chagasi<\/italic> isolates obtained from Brazilian patients with different treatment outcomes","volume":"108","author":"JB Carnielli","year":"2014","journal-title":"J Proteomics"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"TP Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/infdis\/jiu039","article-title":"Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure","volume":"210","author":"TP Dorlo","year":"2014","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e1657","DOI":"10.1371\/journal.pntd.0001657","article-title":"Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis","volume":"6","author":"V Bhandari","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"<italic>Leishmania<\/italic> resistance to miltefosine associated with genetic marker","volume":"18","author":"S Cojean","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00436-014-3835-7","article-title":"Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of <italic>Leishmania donovani<\/italic> and <italic>L<\/italic>. <italic>infantum<\/italic>","volume":"113","author":"S Hendrickx","year":"2014","journal-title":"Parasitol Res"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"e1664","DOI":"10.1371\/journal.pntd.0001664","article-title":"Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol","volume":"6","author":"S Hendrickx","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"50","key":"ref14","doi-asserted-by":"crossref","first-page":"49965","DOI":"10.1074\/jbc.M308352200","article-title":"Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from <italic>Leishmania<\/italic> involved in drug resistance","volume":"278","author":"FJ P\u00e9rez-Victoria","year":"2003","journal-title":"J Biol Chem"},{"issue":"33","key":"ref15","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","article-title":"Phospholipid translocation and miltefosine potency require both <italic>L<\/italic>. <italic>donovani<\/italic> miltefosine transporter and the new protein LdRos3 in <italic>Leishmania<\/italic> parasites","volume":"281","author":"FJ P\u00e9rez-Victoria","year":"2006","journal-title":"J Biol Chem"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1128\/AAC.00587-08","article-title":"Characterization of an ABCG-like transporter from the protozoan parasite <italic>Leishmania<\/italic> with a role in drug resistance and transbilayer lipid movement","volume":"52","author":"E Castanys-Mu\u00f1oz","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00436-015-4460-9","article-title":"Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in <italic>Leishmania infantum<\/italic>","volume":"114","author":"S Hendrickx","year":"2015","journal-title":"Parasitol Res"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1086\/595710","article-title":"Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and <italic>Leishmania infantum<\/italic>","volume":"48","author":"L Lachaud","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"24","key":"ref19","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1016\/j.bmcl.2008.10.089","article-title":"Synthesis of BODIPY-labeled alkylphosphocholines with leishmanicidal activity, as fluorescent analogues of miltefosine","volume":"18","author":"V Hornillos","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/BJ20131318","article-title":"Functional role of evolutionarily highly conserved residues, N-glycosylation level and domains of the <italic>Leishmania<\/italic> miltefosine transporter-Cdc50 subunit","volume":"459","author":"S Garc\u00eda-S\u00e1nchez","year":"2014","journal-title":"Biochem J"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1128\/AAC.00866-09","article-title":"<italic>In vitro<\/italic> sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells","volume":"53","author":"R Inoc\u00eancio da Luz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"<italic>In vitro<\/italic> susceptibilities of <italic>Leishmania donovani<\/italic> promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences","volume":"53","author":"M Vermeersch","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","first-page":"407","article-title":"Drug Resistance in Leishmania Parasites","author":"L Maes","year":"2013"},{"key":"ref24","article-title":"In vitro selection of miltefosine resistance in promastigotes of <italic>Leishmania donovani<\/italic> from Nepal: genomic and metabolomics characterization","author":"CD Shaw","year":"2015","journal-title":"Mol Microbiol"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"B Langmead","year":"2012","journal-title":"Nat Methods"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ng2053","article-title":"Comparative genomic analysis of three <italic>Leishmania<\/italic> species that cause diverse human disease","volume":"39","author":"CS Peacock","year":"2007","journal-title":"Nature genetics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkp851","article-title":"TriTrypDB: a functional genomic resource for the Trypanosomatidae","volume":"38","author":"M Aslett","year":"2010","journal-title":"Nucleic acids research"},{"issue":"16","key":"ref28","first-page":"2078","article-title":"1000 Genome Project Data Processing Subgroup. The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"JT Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"Resistance to miltefosine in <italic>Leishmania donovani<\/italic> involves a defective inward translocation of the drug","volume":"47","author":"FJ P\u00e9rez-Victoria","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1128\/AAC.01694-08","article-title":"The low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug","volume":"53","author":"MP Sanchez-Ca\u00f1ete","year":"2009","journal-title":"Antimicrobial Agents Chemother"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4269\/ajtmh.13-0096","article-title":"<italic>In vitro<\/italic> susceptibility of <italic>Leishmania donovani<\/italic> to miltefosine in Indian visceral leishmaniasis","volume":"89","author":"VK Prajapati","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/AAC.00707-15","article-title":"<italic>In Vivo<\/italic> Selection of Paromomycin and Miltefosine Resistance in <italic>Leishmania donovani<\/italic> and <italic>L<\/italic>. <italic>infantum<\/italic> in a Syrian Hamster Model","volume":"59","author":"S Hendrickx","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/QAI.0b013e318166af5d","article-title":"Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis","volume":"48","author":"N Bourgeois","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome","volume":"46","author":"R Ter Horst","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/00365540701466215","article-title":"Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients","volume":"40","author":"J Troya","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"19","key":"ref37","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1111\/febs.12449","article-title":"Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species","volume":"280","author":"M Das","year":"2013","journal-title":"FEBS J"},{"issue":"1\u20132","key":"ref38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of <italic>Leishmania<\/italic> to miltefosine: Implications for clinical use","volume":"9","author":"FJ P\u00e9rez-Victoria","year":"2006","journal-title":"Drug Resist Updat"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1017\/S0031182013000140","article-title":"(Post-) Genomic approaches to tackle drug resistance in <italic>Leishmania<\/italic>","volume":"140","author":"M Berg","year":"2013","journal-title":"Parasitology"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1054\/bjoc.2001.1776","article-title":"MDR1 causes resistance to the antitumour drug miltefosine","volume":"84","author":"M Rybczynska","year":"2001","journal-title":"Br J Cancer"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00436-014-3755-6","article-title":"Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant <italic>Leishmania donovani<\/italic>","volume":"113","author":"A Kulshrestha","year":"2014","journal-title":"Parasitol Res"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1586\/14787210.2014.916614","article-title":"Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?","volume":"12","author":"M Vanaerschot","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00436-012-3222-1","article-title":"Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their <italic>in vitro<\/italic> drug susceptibility pattern","volume":"112","author":"J Mishra","year":"2013","journal-title":"Parasitol Res"},{"issue":"5","key":"ref44","first-page":"e00611","article-title":"Relapse after Treatment with Miltefosine for Visceral Leishmaniasis Is Associated with Increased Infectivity of the Infecting Leishmania donovani Strain","volume":"4","author":"K Rai","year":"2013","journal-title":"mBio"},{"issue":"14","key":"ref45","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1007\/s00216-014-7772-1","article-title":"Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in <italic>Leishmania<\/italic>","volume":"406","author":"GA Canuto","year":"2014","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1128\/AAC.04231-14","article-title":"Experimental resistance to drug combinations in <italic>Leishmania donovani<\/italic>: metabolic and phenotypic adaptations","volume":"59","author":"M Berg","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2007.05.007","article-title":"Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of <italic>Leishmania donovani<\/italic> and persists <italic>in vivo<\/italic>","volume":"30","author":"K Seifert","year":"2007","journal-title":"Int J Antimicrob Agents"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:45:43Z","timestamp":1589003143000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154101"}},"subtitle":[],"editor":[{"given":"Abhay R","family":"Satoskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,28]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154101","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726319035.793523082","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,28]]}}}